Neoteryx has been acquired by Trajan Group Holdings

Neoteryx, LLC has been sold to Trajan Group Holdings Limited.

Neoteryx, based in Southern California, is a global leader in blood micro-sampling, with operations in the USA and Europe. Its customers include scientific researchers, laboratories and health providers working to advance telemedicine, pharmaceutical development, biotechnology research and clinical diagnostics.

Trajan Group Holdings is a global developer and manufacturer of analytical and life sciences products and devices used in the analysis of biological, food, water and other environmental samples. The company has more than 520 employees, operating across the USA, Australia, Europe and Malaysia.

One of Oaklins’ teams in the USA served as the exclusive financial advisor to Neoteryx, LLC in this transaction.

Service

M&A sell-side

Parties

“At Neoteryx we developed innovative technology to transform specimen collection, and our goal was to achieve global commercial scale through a strategic transaction. The Oaklins team brought deep industry expertise and relationships to this assignment and a sharp focus on achieving our objectives. Our partnership with Trajan is an exciting outcome for the Neoteryx team and our customers as we together leverage micro-sampling to create advanced healthcare solutions.”

Fasha Mahjoor

Founder and CEO, Neoteryx, LLC

Talk to the deal team

Michael S. Goldman

Managing Director

New York, United States
Oaklins TM Capital

View profile Get in touch

John Dean

Managing Director

Atlanta, United States
Oaklins TM Capital

View profile Get in touch

James McLaren

Managing Director

New York, United States
Oaklins TM Capital

View profile Get in touch

Related deals

MEDIK Hospital Design Group has been acquired by STERIS

Construction & Engineering Services | Healthcare

MEDIK Hospital Design Group has been acquired by STERIS

The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc. Together, MEDIK and STERIS will expand their offerings for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to strengthen its position as a leading provider of turnkey room solutions in surgical and IPT environments. The MEDIK management team will actively support the next phase of growth.

Learn more

bioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG

Healthcare

bioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG

Rancoderm GmbH has been acquired by Rose Investment- und Beteiligungs AG to secure the funding required for the final development and market approval of its medical device DermaPro. The acquisition will enable Rancoderm to bring DermaPro to market readiness and launch it as a certified medical product for broad distribution.

Learn more

SLT has been acquired by Indutrade

Healthcare

SLT has been acquired by Indutrade

SLT S.r.l. has been acquired by Indutrade AB and will be integrated into the group’s life science business area. The transaction is Indutrade’s fifth acquisition in 2025 and is expected to have a marginally positive impact on the group’s earnings per share.

Learn more